Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nirmal Kumar Jain

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Lung India : Official Organ of Indian Chest Society|July 14, 2021
WHO consolidated guidelines on tuberculosis 2020 moving toward fully oral regimen: Should country act in hurry?Nirmal Kumar Jain
Lung India : Official Organ of Indian Chest Society|September 5, 2017
Chronic obstructive pulmonary disease and tuberculosisNirmal Kumar Jain
Lung India : Official Organ of Indian Chest Society|July 18, 2022
Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drugNirmal Kumar Jain
Lung India : Official Organ of Indian Chest Society|October 9, 2010
RNTCP and tuberculosis control - High time to actNirmal Kumar Jain
Lung India : Official Organ of Indian Chest Society|February 27, 2025
Newer research transforming 24-month treatment of MDR/XDR-TB TO 6 monthsNitin Jain, Divyam Sharma, Nirmal Kumar Jain
Lung India : Official Organ of Indian Chest Society|February 2, 2017
Respiratory disease terminology: Discordance between pulmonologists and patientsNishtha Singh, Sheetu Singh, Nirmal Kumar Jain, et al.
Scientific Reports|June 15, 2017
Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trialSurendra K Sharma, Kiran Katoch, Rohit Sarin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Lung India : Official Organ of Indian Chest Society|July 14, 2021
WHO consolidated guidelines on tuberculosis 2020 moving toward fully oral regimen: Should country act in hurry?Nirmal Kumar Jain
Lung India : Official Organ of Indian Chest Society|September 5, 2017
Chronic obstructive pulmonary disease and tuberculosisNirmal Kumar Jain
Lung India : Official Organ of Indian Chest Society|July 18, 2022
Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drugNirmal Kumar Jain
Lung India : Official Organ of Indian Chest Society|October 9, 2010
RNTCP and tuberculosis control - High time to actNirmal Kumar Jain
Lung India : Official Organ of Indian Chest Society|February 27, 2025
Newer research transforming 24-month treatment of MDR/XDR-TB TO 6 monthsNitin Jain, Divyam Sharma, Nirmal Kumar Jain
Lung India : Official Organ of Indian Chest Society|February 2, 2017
Respiratory disease terminology: Discordance between pulmonologists and patientsNishtha Singh, Sheetu Singh, Nirmal Kumar Jain, et al.
Scientific Reports|June 15, 2017
Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trialSurendra K Sharma, Kiran Katoch, Rohit Sarin, et al.
Pageof 1